Betaine And Homocysteine — The Methyl Donor Nobody Mentions
Quick Read Your body has two separate systems for recycling homocysteine, an amino acid that builds up after you eat
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Passionflower is a climbing vine with centuries of traditional use as a calming agent, and recent clinical research is backing up that reputation. Multiple controlled trials show it reduces anxiety and improves sleep quality without causing the cognitive impairment or dependence risk associated with prescription anxiety drugs like benzodiazepines. The plant appears to work by influencing several brain systems including GABA, which acts as your nervous system’s natural brake pedal, as well as serotonin and adenosine pathways.
Head-to-head comparisons have found passionflower performs comparably to pharmaceutical anxiolytics like midazolam in reducing pre-operative anxiety. A 2024 study of 65 adults showed significant stress reduction and better sleep within 15 days, while earlier research found that even a simple cup of passionflower tea improved sleep quality. No serious adverse effects were reported across the trials reviewed.
The main caveats are that the evidence base remains relatively small, with most studies running 30 days or less, and we lack long-term safety data. Importantly, product quality varies dramatically, with a 2025 analysis finding that five out of six commercial supplements failed quality checks, while registered herbal products passed. This means choosing a quality-verified product matters as much as the ingredient itself.
Verdict: For moderate stress-related sleep disruption, passionflower backed by a standardised extract from a quality-verified source is a low-risk, biologically plausible option supported by multiple controlled trials, though it appears most useful for moderate rather than severe anxiety.
What if one of the most effective natural calming agents in traditional medicine turned out to work through a remarkably similar mechanism to prescription anxiety drugs, just more gently, and without the side effects that make those drugs so problematic for long-term use? That’s not a headline from a wellness blog clutching at straws. It’s an observation that emerges when you look carefully at the science behind passionflower (*Passiflora incarnata*), a climbing vine with a long folk history as a sedative and stress reliever that has, over the past two decades, attracted genuine clinical attention. From Vitacuity’s analysis of over 1.77 million research papers, 15 studies on passionflower rose to the top as the most relevant and rigorous. Here’s what they actually tell us, and where the honest gaps remain.
To understand why passionflower might help with stress and anxiety, you need to understand one key brain chemical: GABA, or gamma-aminobutyric acid. Think of GABA as your nervous system’s natural brake pedal. It’s an inhibitory neurotransmitter, meaning it slows down neural activity. When your brain is flooded with stress signals, GABA steps in to dampen the noise and restore calm.
Prescription anxiolytics like benzodiazepines (think diazepam) work by binding to GABA receptors and amplifying this braking effect. They’re effective, but they come with serious downsides: sedation, cognitive impairment, and the real risk of dependence. Here’s where passionflower becomes interesting.
The active compounds in *Passiflora incarnata*, primarily flavonoids (plant pigments), alkaloids, and glycosides, appear to modulate the GABA system, but in a more nuanced, gentler way than pharmaceuticals [1]. Rather than forcing the GABA receptors into overdrive, passionflower seems to work alongside them, influencing the system without the blunt-force pharmacology of benzodiazepines [13].
But the mechanism doesn’t stop at GABA. More recent laboratory research has revealed that *P. incarnata* extract also interacts with adenosine receptors (A1 and A2A), serotonin receptors (5-HT2A), and inhibits the reuptake of dopamine, norepinephrine and serotonin, essentially slowing the rate at which these mood-relevant neurotransmitters are cleared from the brain [2]. In plain English: passionflower may help keep calming and mood-stabilising chemicals in circulation for longer.
This multi-target profile, acting on GABA, serotonin, adenosine and monoamine systems simultaneously, might explain why passionflower seems to address both anxiety and sleep disruption rather than just one or the other [2, 3].
Evidence grade: Promising, several RCTs, but limited sample sizes and mostly short duration
Some of the most striking findings come from head-to-head comparisons of passionflower against established pharmaceutical anxiolytics in clinical settings.
A 2025 literature review published in the *Pakistan Journal of Biological Sciences* examined the evidence for passionflower as an anxiolytic in oral surgery and dental settings, environments where pre-procedure anxiety is common, measurable, and ethically well-suited for testing calming interventions [1]. The review drew on multiple randomised controlled trials and found that passionflower performed *comparably to midazolam and oxazepam*, both standard pharmaceutical anxiolytics, in reducing pre-operative anxiety, but with a notably cleaner side effect profile: no significant cognitive impairment, no psychomotor effects (meaning patients could still function normally), and minimal dependence risk.
This is worth sitting with for a moment. Midazolam is a benzodiazepine-class drug used in clinical settings precisely because it’s fast and powerful. The fact that a plant extract performs in a comparable range, even in controlled trials, is not nothing. The caveat, which the review is clear about, is that these studies vary in their formulations, doses and populations, and larger multicenter trials are still needed before we can call this definitively established [1].
A comprehensive 2020 systematic review in the journal *Nutrients* examined nine clinical trials specifically testing *Passiflora incarnata* for neuropsychiatric conditions, including anxiety, stress, and insomnia [6]. Across those trials, the majority reported reduced anxiety levels following passionflower supplementation. Importantly, no adverse effects were observed, including no memory loss or impairment of psychometric function. The review noted one nuance worth knowing: the anxiety-reducing effect appeared less pronounced in people with only mild anxiety symptoms at baseline, suggesting passionflower may be most useful for those experiencing moderate, rather than minimal, levels of stress [6].
Evidence grade: Promising, RCT with 65 participants over 30 days
A 2024 randomised, double-blind, placebo-controlled trial published in *Cureus* tested a standardised *Passiflora incarnata* extract (called SIVI) on 65 Indian adults with both stress and insomnia [4]. Participants were split into two groups: 32 taking the passionflower extract and 33 taking placebo, for 30 days. Stress was measured using the Perceived Stress Scale, sleep quality using the Insomnia Severity Index, and overall psychological wellbeing using the General Health Questionnaire (GHQ-12).
The results at day 15 and day 30 were statistically significant in favour of passionflower: reduced stress scores on the Perceived Stress Scale, improved total sleep time, and improved general psychological health, all compared to placebo. No adverse effects were reported.
The limitations are real: 65 participants is a small sample, the duration was just 30 days, and the study was conducted in a single population. But as an RCT with objective measures and placebo control, it adds meaningful weight to the evidence base, particularly for people in the 40-65 demographic who may be dealing with the intersection of life stress and disrupted sleep [4].
Evidence grade: Promising, small RCT (41 participants), short duration, healthy adults
In 2011, a double-blind, placebo-controlled trial published in *Phytotherapy Research* tested something refreshingly accessible: passionflower herbal tea [8]. Forty-one participants aged 18-35 consumed a cup of passionflower tea or placebo tea each evening for a week, kept sleep diaries, and ten participants also underwent overnight polysomnography (a clinical measure of sleep architecture).
Of six sleep diary measures analysed, sleep quality showed a statistically significant improvement for passionflower versus placebo (t(40) = 2.70, p < 0.01). The polysomnography data didn't reach significance, likely because only ten participants underwent it, but the subjective sleep quality finding in the full group was clear.
This is a low-dose intervention (a single cup of tea) with a short window. It doesn’t tell us much about long-term use or effects on clinical anxiety. What it does suggest is that even a modest amount of passionflower, taken in the most ordinary form imaginable, produces a measurable and meaningful improvement in how people feel about their sleep [8].
Evidence grade: Promising, crossover RCT, 31 participants, 14 days
A 2022 study published in the *Journal of Psychopharmacology* tested a multi-herb extract preparation called Euphytose®, containing valerian, passionflower, hawthorn, and ballota, in a crossover design with 31 healthy adults aged 19-58 [11]. Participants took the formula or placebo for 14 days each (with a 28-day washout period), then faced a standardised laboratory stressor.
The results showed that the herbal preparation significantly reduced subjective tension-anxiety scores. More interestingly, it also reduced two objective physiological markers of stress: electrodermal skin conductance (a measure of the skin’s electrical response to stress, which increases when we’re anxious) and salivary alpha-amylase (an enzyme that rises with sympathetic nervous system activation, in other words, with stress). Cortisol levels trended lower but didn’t reach statistical significance.
The honest caveat here is that this was a combination formula, we can’t attribute the effects specifically to passionflower alone. But the inclusion of passionflower alongside the objective physiological findings is encouraging, and it adds to the picture of a plant whose effects may extend beyond mere subjective feeling [11].
Evidence grade: Early stage, in vitro and animal data, human trials needed
Two entries in the research database (both relating to the same laboratory study, published in the *Journal of Ethnopharmacology*) shed new light on how passionflower works at the receptor level [2, 10]. Using competitive binding and uptake assays, essentially measuring how strongly passionflower extract competes with known receptor-binding compounds in the lab, researchers found that the extract inhibited binding at adenosine A1 and A2A receptors and at serotonin 5-HT2A receptors, in a concentration-dependent manner.
It also inhibited the reuptake of dopamine, norepinephrine, and serotonin into rat brain cortical cells, meaning these neurotransmitters remained active for longer in the synapse.
Adenosine is worth knowing about: it’s a molecule that accumulates in the brain the longer you’re awake and contributes to the feeling of sleepiness. Caffeine works partly by blocking adenosine receptors. Passionflower appears to activate them, nudging the brain toward rest rather than arousal [2]. This mechanism is distinct from the GABA pathway and represents a genuinely new explanation for the plant’s effects.
This is lab and animal research, not human trial data. But it tells us something important: the science behind passionflower’s traditional reputation is considerably richer and more mechanistically sophisticated than “it sort of relaxes you” [2, 10].
Evidence grade: Strong evidence that product quality is highly variable; practically important
Here’s a finding that may be more important than any anxiolytic effect size: a 2025 analytical study published in *Planta Medica* found that 5 out of 6 passionflower food supplements tested failed to meet the specified content and identity standards for their key active compounds, the flavones [5]. One product contained only a single compound (hyperoside) and was missing other passionflower-related substances entirely. All five registered herbal medicinal products tested passed.
The researchers characterised this as potential “food fraud”, products marketed as passionflower that don’t actually contain what the label implies [5].
This matters enormously when trying to interpret the research. Many clinical trials use standardised extracts, carefully characterised preparations where the active compound content is verified. If you pick up a cheap supermarket supplement without quality certification, you may be getting something very different. The implication is clear: if you’re going to try passionflower, the quality and source of the product matters as much as the evidence for the ingredient itself [5].
Let’s be straightforward about the gaps, because there are real ones.
The evidence base is still relatively small. The 2020 systematic review in *Nutrients* found only nine eligible clinical trials, covering very different populations, different doses, different formulations and durations ranging from a single day to 30 days [6]. The 2024 RCT had 65 participants [4]. The tea study had 41 [8]. These are not large numbers by pharmaceutical trial standards.
We don’t have strong data on long-term use. Almost all the clinical trials ran for 30 days or less. What happens to passionflower’s effects, or safety profile, with months of continuous use? We genuinely don’t know yet [1, 6].
The active compounds haven’t been pinned down. The 2010 pharmacognosy research in *Phytotherapy Research* showed that *Passiflora incarnata* itself has distinct chemotypes, meaning plants of the same species can contain quite different chemical profiles depending on where and how they’re grown [9]. The researchers even found two distinct groups based on their flavone content. This makes standardisation complex and means that “passionflower” in one study may not be the same as “passionflower” in another.
Most mechanistic research is pre-clinical. The fascinating multi-receptor findings [2, 10] were conducted in vitro (in test tubes and cell preparations) and in rat brain tissue. These findings are genuinely interesting and biologically plausible, but they haven’t been confirmed in human subjects in ways that let us draw firm conclusions about dose-response relationships.
Combination studies are hard to unpick. The Euphytose® study [11] combined four herbs. Attributing the effects to passionflower specifically, as opposed to valerian or hawthorn, isn’t possible from that data alone.
Interactions with other drugs. The 2026 narrative review in *Plants* noted that while passionflower showed acceptable safety at recommended doses, the review recommended caution regarding potential interactions with CNS depressants, a reasonable flag for anyone taking sedating medication [3].
Here’s what a sensible, informed person would take from all of this.
Passionflower has a genuinely interesting evidence base, not a miraculous one, but a real and growing one. It’s not peer-reviewed magic. But it’s not folk nonsense either. Multiple controlled trials show it reduces anxiety and improves sleep, a systematic review covering nine trials found consistent benefits without adverse effects, and the mechanistic research suggests it’s working through real, well-understood neurobiological pathways, GABA, adenosine, serotonin and monoamine reuptake [1, 2, 6, 13].
For someone in their 40s, 50s or 60s dealing with the kind of moderate, persistent stress that disrupts sleep and frays the edges of daily life, this looks like a reasonable thing to try. Here’s the practical logic:
On safety: Passionflower has a well-documented safety profile at normal doses across multiple clinical trials, with no significant adverse effects reported [1, 4, 6]. It doesn’t cause cognitive impairment or create dependence risk in the way that pharmaceutical anxiolytics do [1]. For healthy adults not taking CNS depressants, the risk profile is very low.
On dose: The clinical trials used various preparations, but a standardised extract at bedtime appears to be the most studied and sensible approach, consistent with the 2024 RCT which found significant effects within 15 days at a dose taken at bedtime [4].
On product quality: This is not a supplement category where you should buy the cheapest option. The 2025 analytical study is a genuine warning flag, five out of six food supplements failed quality checks [5]. Look for registered herbal medicinal products (which are regulated more strictly in the UK and EU) or supplements that explicitly state they use a standardised extract with verified flavone content. This isn’t marketing language, it’s the difference between taking an evidence-based dose and taking something that might be mostly filler.
On expectations: Passionflower appears most effective for moderate anxiety and stress-related sleep disruption. If your anxiety is mild, the evidence suggests the effect may be less pronounced [6]. If it’s severe or clinical, this isn’t a replacement for professional support.
The practical move: If you’re dealing with stress-related sleep disruption or moderate daily anxiety, a standardised passionflower extract taken at bedtime for 30 days is a low-risk, biologically plausible intervention supported by multiple controlled trials. Give it a proper trial, at least two to four weeks, and use a quality-verified product.
It won’t replace everything. But for a climbing vine that humans have been turning to for calm for centuries, the science is catching up rather nicely.
[1] Anxiolytic Potential of *Passiflora incarnata* (2025). DOI: 10.3923/pjbs.2025.483.489 | https://pubmed.ncbi.nlm.nih.gov/41392563/
[2] A *Passiflora incarnata* extract exerts multi-target effects on selected sleep-related receptors (2027). DOI: 10.1016/j.jep.2026.122198 | https://pubmed.ncbi.nlm.nih.gov/42462921/
[3] Neuroprotective and Neuromodulatory Potential of *Valeriana officinalis*, *Passiflora incarnata*, and *Ginkgo biloba*: Efficacy, Safety, and Regulatory Aspects (2026). DOI: 10.3390/plants15172694 | https://pubmed.ncbi.nlm.nih.gov/42739461/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13567466/
[4] Randomized, Double-Blind, Placebo-Controlled, Clinical Study of *Passiflora incarnata* in Participants With Stress and Sleep Problems (2024). DOI: 10.7759/cureus.56530 | https://pubmed.ncbi.nlm.nih.gov/38646244/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11026993/
[5] Passionflower (*Passiflora incarnata*): Quality of Food Supplements Versus Registered Herbal Medicinal Products (2025). DOI: 10.1055/a-2591-3765 | https://pubmed.ncbi.nlm.nih.gov/40245939/
[6] *Passiflora incarnata* in Neuropsychiatric Disorders, A Systematic Review (2020). DOI: 10.3390/nu12123894 | https://pubmed.ncbi.nlm.nih.gov/33352740/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766837/
[8] A double-blind, placebo-controlled investigation of the effects of *Passiflora incarnata* (passionflower) herbal tea on subjective sleep quality (2011). https://pubmed.ncbi.nlm.nih.gov/21294203/
[9] Pharmacognosy and chemotypes of passionflower (*Passiflora incarnata* L.) (2010). https://pubmed.ncbi.nlm.nih.gov/20522969/
[10] A *Passiflora incarnata* extract exerts multi-target effects on selected sleep-related receptors (2027). DOI: 10.1016/j.jep.2026.122198 | https://pubmed.ncbi.nlm.nih.gov/42462921/
[11] The chronic effects of a combination of herbal extracts (Euphytose®) on psychological mood state and response to a laboratory stressor: A randomised, placebo-controlled, double blind study in healthy humans (2022). DOI: 10.1177/02698811221112933 | https://pubmed.ncbi.nlm.nih.gov/35875924/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643820/
[12] Behavioral Pharmacology of Five Uncommon *Passiflora* Species Indicates Sedative and Anxiolytic-like Potential (2022). DOI: 10.2174/1871524922666220426102650 | https://pubmed.ncbi.nlm.nih.gov/35473529/
[13] GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence (2018). https://pubmed.ncbi.nlm.nih.gov/29168225/
[14] Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence (2013). https://pubmed.ncbi.nlm.nih.gov/23653088/
[15] Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian (2009). https://pubmed.ncbi.nlm.nih.gov/19865069/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Your body has two separate systems for recycling homocysteine, an amino acid that builds up after you eat
Quick Read B vitamins become increasingly important for brain health after 40 because your body absorbs them less efficiently with
The nutrients that matter, the forms that work, and the claims to ignore.
